ABCA1 and atherosclerosis: Indeed, activation of LXRs reduces serum cholesterol and increases ABCA1-mediated cholesterol transport in humans and mouse/primate models of atherosclerosis (Calkin and Tontonoz, 2011; Muse et al., 2018), mainly by modulating lipid load in macrophages (Zhang et al., 2014).